Both in Pharmaceuticals
Sarepta Therapeutics, vs Harmony Biosciences Holdings
Over the past year SRPT returned +17.2% and HRMY returned +12.0%; their daily moves had a correlation of 0.30.
SRPT +17.2% HRMY +12.0%Growth of $1, one year, split-adjusted
| Metric | SRPT | HRMY |
|---|---|---|
| Price | $18.99 | $34.42 |
| Market cap | $2.01B | $2.00B |
| Today | +2.43% | −7.04% |
| 1 month | +9.7% | −12.6% |
| 6 months | −17.5% | +5.0% |
| Year to date | −11.8% | −8.0% |
| 1 year | −22.3% | +17.3% |
| Revenue growth (YoY) | −34.3% | +30.3% |
| Gross margin | 62.8% | 75.8% |
| Net margin | −1.2% | 28.9% |
| P/E (TTM) | — | 11.1× |
| Price / sales | 1.0× | 2.1× |
| Net cash | -$59.1M | $513.8M |
| Dividend yield | — | — |
| Volatility (60d) | 61.6% | 35.9% |
| Short % of float | 22.7% | 11.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).